Immuneering Statistics
Total Valuation
Immuneering has a market cap or net worth of $62.57 million. The enterprise value is $14.08 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Immuneering has 29.65 million shares outstanding. The number of shares has increased by 6.64% in one year.
Current Share Class | 29.65M |
Shares Outstanding | 29.65M |
Shares Change (YoY) | +6.64% |
Shares Change (QoQ) | +0.64% |
Owned by Insiders (%) | 29.21% |
Owned by Institutions (%) | 14.78% |
Float | 20.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.10 |
P/TBV Ratio | 1.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.99, with a Debt / Equity ratio of 0.07.
Current Ratio | 7.99 |
Quick Ratio | 7.32 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -71.81% and return on invested capital (ROIC) is -45.31%.
Return on Equity (ROE) | -71.81% |
Return on Assets (ROA) | -42.35% |
Return on Capital (ROIC) | -45.31% |
Revenue Per Employee | n/a |
Profits Per Employee | -$853,950 |
Employee Count | 68 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.19% in the last 52 weeks. The beta is -0.40, so Immuneering's price volatility has been lower than the market average.
Beta (5Y) | -0.40 |
52-Week Price Change | -62.19% |
50-Day Moving Average | 2.22 |
200-Day Moving Average | 2.28 |
Relative Strength Index (RSI) | 55.23 |
Average Volume (20 Days) | 342,625 |
Short Selling Information
The latest short interest is 2.05 million, so 6.90% of the outstanding shares have been sold short.
Short Interest | 2.05M |
Short Previous Month | 1.52M |
Short % of Shares Out | 6.90% |
Short % of Float | 9.74% |
Short Ratio (days to cover) | 1.19 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -61.82M |
Pretax Income | -56.07M |
Net Income | -58.07M |
EBITDA | -61.43M |
EBIT | -61.82M |
Earnings Per Share (EPS) | -$1.97 |
Full Income Statement Balance Sheet
The company has $50.66 million in cash and $4.24 million in debt, giving a net cash position of $46.42 million or $1.57 per share.
Cash & Cash Equivalents | 50.66M |
Total Debt | 4.24M |
Net Cash | 46.42M |
Net Cash Per Share | $1.57 |
Equity (Book Value) | 57.72M |
Book Value Per Share | 1.86 |
Working Capital | 48.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$52.26 million and capital expenditures -$246,437, giving a free cash flow of -$52.51 million.
Operating Cash Flow | -52.26M |
Capital Expenditures | -246,437 |
Free Cash Flow | -52.51M |
FCF Per Share | -$1.77 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |